Statistics for Relay Therapeutics (id:6449 RLAY)

Valuation metrics

Market cap

937.34M

Enterprise value

147.55M

Trailing P/E (ttm)

-1.70

Forward P/E

-2.10

PEG ratio

-2.10

Price/Sales (ttm)

93.68

Price/Book (mrq)

1.11

Enterprise Value/Revenue

14.75

Enterprise Value/EBITDA

-0.38

Overview

Shares outstanding

167.38M

Float

128.15M

Shares short

12.04M

% Held by insiders

0.02%

% Held by institutions

0.84%

Average volume (10 days)

1.34M

Average volume (90 days)

Price summary

52-Week low

4.48

52-Week high

12.14

52-Week change

-70.32%

Beta

1.68

50-Day moving average

6.75

200-Day moving average

7.45

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-3,947.21%

Operational effectiveness

Return on assets

-26.87%

Return on equity

-42.69%

Income statement

Revenue (ttm)

0.08

Revenue per share (ttm)

0.08

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-389,452,992.00

Net income to common (ttm)

-345,199,008.00

Diluted EPS (ttm)

-2.52

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

839.61M

Total cash per share (mrq)

5.02

Total debt (mrq)

49.82M

Total Debt/Equity (mrq)

5.94

Current ratio (mrq)

1.84K%

Book value per share (mrq)

5.03

Cash flow

Cash flow statement

-280,427,008.00

Levered free cash flow (LFCF)

-156,569,744.00